Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people

The human brain is a complex organ that can be affected by infections in ways that are not always immediately obvious. While many people know that viruses can cause fever or coughing, scientists have long suspected that some infections might also trigger changes in the brain that lead to memory loss or other neurological problems. This idea has become especially important since the global outbreak of a virus called SARS-CoV-2, which causes the disease known as COVID-19. Early reports suggested that people who survived the infection were sometimes left with lingering symptoms, including confusion or difficulty thinking clearly. However, it remained unclear whether these infections could actually increase the risk of developing serious, long-term conditions like dementia or Parkinson's disease, and whether getting vaccinated against the virus might change that risk. Understanding these connections is vital for public health, as it helps doctors and families know what to watch for and how to care for people who have been sick.

To answer these questions, researchers conducted a massive study using the medical records of more than 18 million adults in England. They looked at data from general practitioners, hospitals, and national testing databases to track what happened to people after they were diagnosed with COVID-19. The team divided the people they studied into three groups based on when they got sick and whether they had received a vaccine. One group included people who were infected before vaccines were widely available. A second group included those who were infected after they had been vaccinated, and a third group consisted of people who were infected but had not yet been vaccinated. By comparing the rates of new diagnoses for brain-related conditions in these groups against people who had never had the virus, the researchers could see if the infection itself was linked to future health problems.

The study focused on a wide range of conditions, including cognitive impairment (trouble with thinking and memory), dementia (a severe loss of memory and thinking skills), Parkinson's disease, and other neurological disorders. The researchers found that in the weeks immediately following a COVID-19 diagnosis, the number of new cases for many of these conditions jumped significantly. This spike was especially high for cognitive impairment and dementia. For example, in the first month after infection, people who had not been vaccinated were much more likely to receive a new diagnosis of dementia compared to those who had never been infected. This immediate increase was seen across all groups, but it was most pronounced in those who had been hospitalized for their illness.

However, the story changed as time went on. For people who had been vaccinated, the risk of developing dementia dropped back down to levels similar to those who had never been infected within about a year. In contrast, for those who were unvaccinated when they got sick, the risk of cognitive impairment remained elevated for several years. The study showed that four years after infection, unvaccinated individuals still had a higher chance of developing cognitive impairment than those who had not been infected. This pattern was even clearer for people who had been hospitalized with COVID-19; their risk of long-term brain health issues stayed higher for years, regardless of vaccination status, though vaccination still offered some protection.

The researchers also looked at specific types of dementia and other neurological diseases. They found that the risk of vascular dementia, which is caused by problems with blood flow to the brain, remained higher for up to four years in the group infected before vaccines were available. Similarly, a condition called REM sleep behavior disorder, where people act out their dreams, showed a persistent increase in risk after infection. Other conditions, such as Parkinson's disease and multiple sclerosis, showed a small increase in risk right after the infection, but this risk returned to normal levels within a few months. Interestingly, the study found no significant long-term increase in the risk of developing Parkinson's disease or motor neuron disease after the initial few weeks.

One of the most important findings was that the severity of the initial illness mattered greatly. People who were hospitalized with COVID-19 faced a much higher risk of developing long-term brain conditions than those who were sick but stayed at home. This was true for both vaccinated and unvaccinated people, though vaccination still reduced the overall risk. The study also noted that people who had been unvaccinated when they got sick were generally younger and less likely to have visited a doctor recently, which made the unvaccinated group distinct from the others. Despite these differences, the link between the infection and long-term brain health issues remained clear.

The researchers were careful to note that their study had limitations. Because they relied on medical records, they could only count cases that were officially diagnosed by a doctor. This means the true number of people affected might be higher, especially for mild cases of memory loss that go unreported. Additionally, the study could not track every single infection, as some people may have had the virus without ever getting tested or seeing a doctor. The team also acknowledged that people who were sick with COVID-19 might have visited doctors more often for other reasons, which could have led to more diagnoses of brain conditions simply because they were being watched more closely. However, the patterns they saw were strong and consistent across different groups of people.

Ultimately, this research provides a clear picture of how COVID-19 affects the brain over the long term. It suggests that while the virus can trigger a wave of new neurological diagnoses shortly after infection, the long-term risk depends heavily on whether a person was vaccinated and how sick they were. Vaccination appears to be a powerful tool in reducing the chance of developing dementia years after the infection, though the risk of cognitive impairment may remain elevated for longer in unvaccinated individuals. For those who were unvaccinated or severely ill, the risk remains higher for a longer period. These findings highlight the importance of continued monitoring for people who have had COVID-19, particularly those who were not vaccinated or who required hospital care, so that any new concerns about memory or thinking can be addressed early.